Goldman Sachs
ACHV icon

Goldman Sachs’s Achieve Life Sciences ACHV Stock Holding History

Goldman Sachs’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13
Closed -$103K – 7096
2014
Q2 		$103K Sell
13
-4
-24% -$49.1K ﹤0.01% 6534
2014
Q1 		$443K Buy
+17
New +$418K ﹤0.01% 5395

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Goldman Sachs's ACHV Position: Q2 2026 in Review

Goldman Sachs reduced its Achieve Life Sciences (ACHV) stake by 73% in Q2 2026, selling an estimated $534K and leaving 40,976 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #6054.

Goldman Sachs first reported a position in ACHV in Q1 2014 and has held it in 26 quarters since. The position peaked at $2.24M in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Goldman Sachs held 40,976 shares of Achieve Life Sciences worth $268K as of Q2 2026.
  • Goldman Sachs sold 111,976 Achieve Life Sciences shares in Q2 2026, an estimated $534K.
  • Achieve Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6054 holding.
  • Goldman Sachs first reported a position in Achieve Life Sciences in Q1 2014 and has held it in 26 quarters since.
  • Goldman Sachs's Achieve Life Sciences position peaked at $2.24M in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.